Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,166,450 | N/A | 16,132,400 | 13,963,500 | 13,899,440 |
| Marketable Securities | 330,490 | N/A | 717,530 | 1,290,180 | 2,079,350 |
| Receivables | 2,821,020 | N/A | 2,236,380 | 1,966,980 | 1,774,170 |
| Inventories | 1,480,610 | N/A | 1,161,310 | 892,430 | 839,810 |
| Other current assets | 3,114,050 | 3,080,730 | 2,190,300 | 1,867,520 | 1,680,470 |
| TOTAL | $16,912,620 | $3,080,730 | $22,437,920 | $19,980,610 | $20,273,240 |
| Non-Current Assets | |||||
| PPE Net | 3,646,840 | N/A | 2,361,340 | 2,210,560 | 2,042,940 |
| Investments And Advances | 2,127,370 | 1,929,870 | 3,144,020 | 3,344,440 | 3,315,930 |
| Other Non-Current Assets | 7,670,920 | 8,327,300 | 549,510 | 502,500 | 370,380 |
| TOTAL | $13,445,130 | $10,257,170 | $6,054,870 | $6,057,500 | $5,729,250 |
| Total Assets | $30,357,780 | $13,337,900 | $28,492,790 | $26,038,140 | $26,002,510 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 37,320 | 22,430 | 8,000 | 11,860 | 17,740 |
| Accounts payable and accrued liabilities | 750,800 | 656,230 | 690,360 | 467,670 | 433,490 |
| Accrued Expenses | 1,765,910 | 1,407,300 | 1,751,860 | 1,315,600 | 1,429,010 |
| Other current liabilities | 1,499,240 | 1,965,030 | 896,430 | 1,031,170 | 933,790 |
| TOTAL | $4,607,270 | $4,817,380 | $4,287,110 | $3,749,210 | $4,172,880 |
| Non-Current Liabilities | |||||
| Long Term Debt | 166,870 | N/A | 12,500 | 17,370 | 29,680 |
| Other Non-Current Liabilities | 782,800 | 762,710 | 368,390 | 357,950 | 820,000 |
| TOTAL | $2,473,650 | $2,208,580 | $980,350 | $1,432,000 | $1,757,560 |
| Total Liabilities | $7,080,940 | $7,025,960 | $5,267,460 | $5,181,220 | $5,930,470 |
| Shareholders' Equity | |||||
| Common Shares | 683,230 | 648,370 | 635,410 | 538,480 | 543,080 |
| Retained earnings | 23,293,580 | N/A | 25,236,410 | 19,469,810 | 17,625,860 |
| Other shareholders' equity | -1,222,720 | -719,500 | 83,130 | 2,070,960 | 1,504,820 |
| TOTAL | $23,276,830 | $424,380 | $23,225,330 | $20,856,910 | $20,072,040 |
| Total Liabilities And Equity | $30,357,770 | $7,450,340 | $28,492,790 | $26,038,130 | $26,002,510 |